TY  - JOUR

TI  - The Efficacy and Safety of Levosimendan on Patients with Refractory Heart Failure (ReHF): A systematic review and meta-analysis
JO  - Journal of Cardiovascular Diseases
PY  - 2026
DO  - 10.52338/jocd.2022.1006
ER  -